Mohler MA - Search Results

1

Increase in cyclic AMP levels by relaxin in newborn rhesus monkey uterus cell culture.

Kramer SM, Gibson UE, Fendly BM, Mohler MA, Drolet DW, Johnston PD. Kramer SM, et al. Among authors: mohler ma. In Vitro Cell Dev Biol. 1990 Jun;26(6):647-56. doi: 10.1007/BF02624216. In Vitro Cell Dev Biol. 1990. PMID: 2162818

2

Recombinant human insulin-like growth factor binding protein-3 (rhIGFBP-3): effects on the glycemic and growth promoting activities of rhIGF-1 in the rat.

Clark RG, Mortensen D, Reifsynder D, Mohler M, Etcheverry T, Mukku V. Clark RG, et al. Growth Regul. 1993 Mar;3(1):50-2. Growth Regul. 1993. PMID: 7683530

3

Altered pharmacokinetics of recombinant human deoxyribonuclease in rats due to the presence of a binding protein.

Mohler M, Cook J, Lewis D, Moore J, Sinicropi D, Championsmith A, Ferraiolo B, Mordenti J. Mohler M, et al. Drug Metab Dispos. 1993 Jan-Feb;21(1):71-5. Drug Metab Dispos. 1993. PMID: 8095230

4

Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin.

Darbonne WC, Rice GC, Mohler MA, Apple T, Hébert CA, Valente AJ, Baker JB. Darbonne WC, et al. Among authors: mohler ma. J Clin Invest. 1991 Oct;88(4):1362-9. doi: 10.1172/JCI115442. J Clin Invest. 1991. PMID: 1918386 Free PMC article.

5

Plasma clearance and tissue distribution of labelled insulin-like growth factor-I (IGF-I), IGF-II and des(1-3)IGF-I in rats.

Ballard FJ, Knowles SE, Walton PE, Edson K, Owens PC, Mohler MA, Ferraiolo BL. Ballard FJ, et al. Among authors: mohler ma. J Endocrinol. 1991 Feb;128(2):197-204. doi: 10.1677/joe.0.1280197. J Endocrinol. 1991. PMID: 2005410

6

Saporin toxins directed to basic fibroblast growth factor receptors effectively target human ovarian teratocarcinoma in an animal model.

Davol P, Beitz JG, Mohler M, Ying W, Cook J, Lappi DA, Frackelton AR Jr. Davol P, et al. Cancer. 1995 Jul 1;76(1):79-85. doi: 10.1002/1097-0142(19950701)76:1<79::aid-cncr2820760111>3.0.co;2-g. Cancer. 1995. PMID: 8630880

7

Pharmacokinetics and bioactivity of intact versus truncated IGF-I during a 24-h infusion into lactating goats.

Prosser CG, Davis SR, Hodgkinson SC, Mohler MA. Prosser CG, et al. Among authors: mohler ma. J Endocrinol. 1995 Jan;144(1):99-107. doi: 10.1677/joe.0.1440099. J Endocrinol. 1995. PMID: 7891029

8

A review of nonclinical toxicology studies of becaplermin (rhPDGF-BB).

Knight EV, Oldham JW, Mohler MA, Liu S, Dooley J. Knight EV, et al. Among authors: mohler ma. Am J Surg. 1998 Aug;176(2A Suppl):55S-60S. doi: 10.1016/s0002-9610(98)00176-7. Am J Surg. 1998. PMID: 9777973 Review.

9

Intraocular tissue plasminogen activator concentrations after subconjunctival delivery.

Lim JI, Maguire AM, John G, Mohler MA, Fiscella RG. Lim JI, et al. Among authors: mohler ma. Ophthalmology. 1993 Mar;100(3):373-6. doi: 10.1016/s0161-6420(93)31639-8. Ophthalmology. 1993. PMID: 8460008 Free article.

10

Intraocular penetration of topical tissue plasminogen activator.

Lim JI, Fiscella R, Tessler H, Gagliano DA, Chaques-Alepuz V, Mohler MA. Lim JI, et al. Among authors: mohler ma. Arch Ophthalmol. 1991 May;109(5):714-7. doi: 10.1001/archopht.1991.01080050130043. Arch Ophthalmol. 1991. PMID: 1902662

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters